All in-house stories
Refine search
In-house counsel
Conversations at AI & IP Europe in Brussels prove that in-house IP leaders who 'grasp the nettle'—such as Carola Lempke of AstraZeneca—are becoming essential to their company’s rollout of AI, says Tom Phillips. 18 November 2026
Pharma
From GLP-1 drugs to cancer treatments, counterfeiters are exploiting supply chain weaknesses and AI to evade detection. The US chamber’s director of IP tells LSIPR why the fight against fakes is becoming more complex and what lies ahead. 12 November 2026
In-house counsel
From deciding what to outsource to managing legal fees and foreign counsel relationships, panellists at LSPN Fall, from Addition Therapeutics, Arcus Biosciences and the Law Office of Athena Zhou, shared practical advice for making IP budgets go further. 9 November 2026
Regulation & Industry
Things can go “sideways pretty quickly” if the two sides of pharma protection are not communicating with each other, said a senior panel of industry counsel at LSPN Fall. 5 November 2026
In-house counsel
AI agents are no longer just helping patent lawyers with their workload. Some are now doing the work themselves. In-house counsel from Insitro, Illumina, 10x Genomics and Invenra discuss how much can be handed over and whether humans could be replaced. 4 November 2026
In-house counsel
With budgets under pressure, counsel from Pfizer, ALX Oncology and BioMarin share how they are reassessing portfolios, trimming costs and prioritising key markets at LSPN Fall. 3 November 2026
In-house counsel
Umicore’s Sean Alexander has seen the profession change considerably over three decades, but some of its biggest changes may still lie ahead. He tells LSIPR why AI is prompting difficult decisions, what he is no longer willing to pay external counsel for and why Europe is the place to watch. 26 October 2026
In-house counsel
From building IP teams that are business orientated to tackling M&A challenges, the global head of IP management at Medmix Group—a manufacturer of high-precision delivery, mixing and application devices—explains why close collaboration, trusted external counsel and thorough due diligence matter. 21 October 2026
Regulation & Industry
Potential reforms to post-employment restrictions and contractual notice periods could make it harder for brand owners to protect trade secrets and manage staff departures, prompting questions about how businesses can safeguard their interests. 13 October 2026
In-house counsel
With resources under pressure, the Danish company’s IP leader explains how AI, smarter prioritisation and close business ties can help IP teams boost their impact. 7 October 2026


